Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man

• Published in: Circulation research Vol. 54; no. 4; pp. 447 - 452
• Main Authors: Jie, K, van Brummelen, P, Vermey, P, Timmermans, P B, van Zwieten, P A
• Format: Journal Article
• Language: English
• Published: United States 01-04-1984
• Subjects: Adult; Azepines - pharmacology; Blood Pressure - drug effects; Clonidine - pharmacology; Dose-Response Relationship, Drug; Doxazosin; Female; Guanfacine; Guanidines - pharmacology; Heart Rate - drug effects; Humans; Male; Methoxamine - pharmacology; Muscle, Smooth, Vascular - metabolism; Phenylacetates - pharmacology; Prazosin - analogs & derivatives; Prazosin - pharmacology; Receptors, Adrenergic, alpha - drug effects; Receptors, Neurotransmitter - drug effects; Yohimbine - pharmacology
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/01.RES.54.4.447

We studied postsynaptic alpha-adrenoceptors in human blood vessels by measuring the influence on forearm blood flow induced by intra-arterial infusions of selective alpha 1- and alpha 2-adrenoceptor agonists (methoxamine, B-HT 933, clonidine and guanfacine) and antagonists (doxazosin and yohimbine). The studies were done in healthy volunteers, and forearm blood flow was measured by plethysmography. All agonists produced a significant and dose-dependent vasoconstriction. The effect of B-HT 933 was completely abolished by the concomitant infusion of yohimbine, whereas it was hardly influenced by doxazosin. The effect of methoxamine was prevented by doxazosin and little influenced by yohimbine. The vasoconstriction by clonidine and guanfacine was partially prevented by both doxazosin and yohimbine. The single intra-arterial infusion of yohimbine, as well as doxazosin, resulted in vasodilation. These findings provide strong evidence for the existence of postsynaptic alpha 1- as well as alpha 2-adrenoceptors, both mediating vasoconstriction and contributing to basal vascular tone. The (patho-)physiological significance of this subdivision of alpha-adrenoceptors remains to be elucidated.